Jerneja Mori

Jerneja Mori, PhD, MBA, currently serves as the Head of Development QA Biosimilar Alliance projects at Sandoz, responsible for establishing a global QA team for biosimilar projects, coaching team members, and developing processes for collaboration with CDMOs. Previously, Jerneja held various leadership roles at Novartis, including ESO QA Lead, managing qualifications and quality oversight of API suppliers, and Senior QA Manager for chemicals and anti-infectives. Experience also includes positions at Thermo Fisher Scientific, where Jerneja led QC departments for biologics, and extensive research roles at the National Institute of Chemistry. Educational qualifications encompass a PhD in Biomedicine and an MBA in Business Administration and Management.